Models Exposed

Published Sep 17, 2012
Princeton, NJ, USA – As consumers, we are becoming experts at scrutinizing the reviews our peers write about products we are thinking of buying. We ask ourselves if the comments written in the review truly fit the product, are the comments promotional or too negative, or simply unrelated to the product itself. Health care decision makers are starting to do this with modeling studies. They are asking themselves, “Where is this information coming from? Are the results realistic? Are they relevant to my decision?” Dr. Jaime Caro, co-author on the paper, “Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-7,” states, “For decision makers to trust the results of models, these must be shown to be valid in the sense of being sufficiently accurate and relevant. This subgroup of the ISPOR-SMDM Modeling Task Force detailed the steps required to ensure the validity of models and grappled with the difficult balance between transparency and protection of intellectual property, proposing a compromise that should provide for full scientific review of models.”  This paper provides guidance for health care researchers to ensure that their models are both transparent and valid. This paper is one of the seven papers in the series on modeling study best practices and is jointly published in Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and Medical Decision Making, the official journal of the Society for Medical Decision Making (SMDM).

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health. For more information: www.ispor.org

Related Stories

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.

ISPOR Good Practices Report Offers Guidance for Using Real-World Data From EHRs in Health Technology Assessments

Jun 17, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health technology assessments. The report, “Assessing Real-World Data from Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force” was published in the June 2024 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×